Motoric Cognitive Risk Syndrome
Conditions
Interventions
Intervention group:The intervention group will use the standard M-Mobile multicomponent exercise program as the foundation, while transforming aerobic, resistance, balance, and flexibility training in
Control group:The control group received the standard M-Mobile multicomponent exercise program or routine exercise guidance, without the atom-habit–based behavior shaping strategy.
Sponsors
Zhejiang University School of Medicine
Eligibility
Sex/Gender
All
Age
60 Years to 85 Years
Inclusion criteria
Inclusion criteria: Qualitative research section 1. Age >=60 years old; 2. Meet the diagnostic criteria of MCR; 3. Possess basic communication skills and be able to understand and cooperate with scale evaluations; 4. Voluntarily sign the informed consent form, or have it signed by the legal guardian on one's behalf. Intervention research section 1. Age >=60 years old; 2. Meet the diagnostic criteria of MCR; 3. Have a long-term residence in the local area and have no plan to leave the local area for a long time in the next six months; 4. Possess basic communication skills and be able to understand and cooperate with scale evaluations; 5. Voluntarily sign the informed consent form, or have it signed by the legal guardian on one's behalf.
Exclusion criteria
Exclusion criteria: Qualitative research section 1. Acute disease attack period, severe sensory impairment; 2. Patients with cognitive impairment or mental disorders who are unable to cooperate; 3. Patients with severe physical diseases such as heart, liver and kidney insufficiency. Intervention research section 1. Age >85 years old (referring to similar studies, the actual upper limit of age included is mostly 89 years old, and the risk of falls and fractures among extremely elderly people significantly increases. A reasonable balance should be struck between safety and representativeness); 2. Those suffering from severe or unstable physical diseases, active tumors or serious mental disorders; 3. Clinically confirmed Parkinson's disease or other non-Alzheimer's dementia; 4. Cognitive function has deteriorated rapidly in recent times; 5. Have taken psychotropic drugs or other related medications that may affect cognitive function within the past 30 days; 6. Participated in other interventional clinical studies within the past year.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adherence;Safety; | — |
Secondary
| Measure | Time frame |
|---|---|
| Motor function;Cognitive function;Grip strength;Fall incidence;Fatigue;Exercise self-efficacy;Quality of life; | — |
Countries
China
Contacts
Public ContactYing Liying
Zhejiang University School of Medicine
Outcome results
None listed